Confirmed by numerous studies, IL-17, a pro-tumor cytokine, can be a catalyst for cancer’s emergence by stimulating cell proliferation, creating blood vessels, and intensifying the aggregation and activation of inflammatory cells. Here, IL17A is linked to cancer.